Michael Taffe

Title(s)Professor In Residence, Psychiatry
SchoolHealth Sciences
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    The Colorado College, Colorado Springs, ColoradoB.A.06/1990Experimental Psychology
    University of California, San Diego, La Jolla, CaliforniaPh.D.12/1995Experimental Psychology

    Collapse Overview 
    Collapse Overview
    Research in the Taffe Laboratory focuses on the effects of recreational or abused drugs on the brain and the resulting changes in behavior. We have a current interest in the compulsive use of drugs with a focus on factors involved in the transition from casual to repetitive drug use, as well as on novel therapeutic approaches using the immune system. Additional studies focus on the acute and lasting impact of recreational drug exposure on behavior and physiology.

    Collapse Research 
    Collapse Research Activities and Funding
    Dissecting the Abuse Liability of Synthetic Cathinone Stimulants
    NIH/NIDA R01DA042211Sep 30, 2016 - Jun 30, 2021
    Role: Principal Investigator
    Prescription Opioid Addiction: Neurobiological Mechanisms
    NIH/NIDA R01DA035281Mar 1, 2014 - Feb 28, 2019
    Role: Principal Investigator
    Cannabinoid regulation of cognition
    NIH/NIDA R01DA035482May 1, 2013 - Jan 31, 2018
    Role: Principal Investigator
    Determinants of transition states in MDMA self-administration
    NIH/NIDA R01DA024105Feb 1, 2011 - Nov 30, 2015
    Role: Principal Investigator
    Immunopharmacotherapy for Methamphetamine Addiction
    NIH/NIDA R01DA024705Aug 15, 2008 - May 31, 2019
    Role: Principal Investigator
    Behavioral Toxicity of Chronic Alcohol Drinking in Peri-Adolescent Monkeys
    NIH/NIAAA R01AA016807Aug 10, 2008 - May 31, 2014
    Role: Principal Investigator
    NIH/NIDA R01DA018418Apr 1, 2005 - Mar 31, 2012
    Role: Principal Investigator
    NIH/NIAAA R21AA013972Feb 5, 2004 - Jan 31, 2007
    Role: Principal Investigator
    SIV Behavioral Pathology: Manipulation of Viral Load
    NIH/NIMH R01MH061692Aug 1, 2001 - Jul 31, 2005
    Role: Principal Investigator
    NIH/NIDA R01DA013390Sep 11, 2000 - Jun 30, 2004
    Role: Principal Investigator
    Neuropsychopharmacology: Multidisciplinary Training
    NIH/NIAAA T32AA007456Dec 1, 1983 - Jun 30, 2022
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen JD, Grant Y, Creehan KM, Hwang CS, Vandewater SA, Janda KD, Cole M, Taffe MA. ?9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions. Neuropharmacology. 2019 Apr 10. PMID: 30980837.
      View in: PubMed
    2. Javadi-Paydar M, Kerr TM, Harvey EL, Cole M, Taffe MA. Effects of nicotine and THC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male rats. Drug Alcohol Depend. 2019 Feb 27; 198:54-62. PMID: 30878767.
      View in: PubMed
    3. Nguyen JD, Grant Y, Kerr TM, Gutierrez A, Cole M, Taffe MA. Tolerance to hypothermic and antinoceptive effects of ?9-tetrahydrocannabinol (THC) vapor inhalation in rats. Pharmacol Biochem Behav. 2018 09; 172:33-38. PMID: 30031028.
      View in: PubMed
    4. Nguyen JD, Hwang CS, Grant Y, Janda KD, Taffe MA. Prophylactic vaccination protects against the development of oxycodone self-administration. Neuropharmacology. 2018 08; 138:292-303. PMID: 29936242.
      View in: PubMed
    5. Javadi-Paydar M, Harvey EL, Grant Y, Vandewater SA, Creehan KM, Nguyen JD, Dickerson TJ, Taffe MA. Binge-like acquisition of a-pyrrolidinopentiophenone (a-PVP) self-administration in female rats. Psychopharmacology (Berl). 2018 Aug; 235(8):2447-2457. PMID: 29909425.
      View in: PubMed
    6. Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, Taffe MA. Effects of ?9-THC and cannabidiol vapor inhalation in male and female rats. Psychopharmacology (Berl). 2018 Sep; 235(9):2541-2557. PMID: 29907926.
      View in: PubMed
    7. Taffe MA, Olive MF. Designer drugs - A continuing chemical (R)evolution. Neuropharmacology. 2018 05 15; 134(Pt A):1-3. PMID: 29605651.
      View in: PubMed
    8. Dutta RR, Taffe MA, Mandyam CD. Chronic administration of amphetamines disturbs development of neural progenitor cells in young adult nonhuman primates. Prog Neuropsychopharmacol Biol Psychiatry. 2018 07 13; 85:46-53. PMID: 29601895.
      View in: PubMed
    9. Aarde SM, Huang PK, Taffe MA. High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration. Pharmacol Biochem Behav. 2017 Dec; 163:38-49. PMID: 29054819.
      View in: PubMed
    10. Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and ?9-Tetrahydrocannabinol. Neuropsychopharmacology. 2018 Jan; 43(1):142-154. PMID: 28875990.
      View in: PubMed
    11. Javadi-Paydar M, Nguyen JD, Vandewater SA, Dickerson TJ, Taffe MA. Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats. Neuropharmacology. 2018 05 15; 134(Pt A):57-64. PMID: 28882561.
      View in: PubMed
    12. Vendruscolo JCM, Tunstall BJ, Carmack SA, Schmeichel BE, Lowery-Gionta EG, Cole M, George O, Vandewater SA, Taffe MA, Koob GF, Vendruscolo LF. Compulsive-Like Sufentanil Vapor Self-Administration in Rats. Neuropsychopharmacology. 2018 03; 43(4):801-809. PMID: 28812595.
      View in: PubMed
    13. Nguyen JD, Bremer PT, Hwang CS, Vandewater SA, Collins KC, Creehan KM, Janda KD, Taffe MA. Effective active vaccination against methamphetamine in female rats. Drug Alcohol Depend. 2017 06 01; 175:179-186. PMID: 28437722.
      View in: PubMed
    14. Aarde SM, Taffe MA. Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration. Curr Top Behav Neurosci. 2017; 32:145-164. PMID: 27909988.
      View in: PubMed
    15. Nguyen JD, Bremer PT, Ducime A, Creehan KM, Kisby BR, Taffe MA, Janda KD. Active vaccination attenuates the psychostimulant effects of a-PVP and MDPV in rats. Neuropharmacology. 2017 04; 116:1-8. PMID: 27956054.
      View in: PubMed
    16. Nguyen JD, Aarde SM, Cole M, Vandewater SA, Grant Y, Taffe MA. Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology. Neuropsychopharmacology. 2016 10; 41(11):2759-71. PMID: 27277119; PMCID: PMC5026745 [Available on 10/01/17].
    17. Nguyen JD, Aarde SM, Vandewater SA, Grant Y, Stouffer DG, Parsons LH, Cole M, Taffe MA. Inhaled delivery of ?(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology. Neuropharmacology. 2016 10; 109:112-120. PMID: 27256501; PMCID: PMC4970926 [Available on 10/01/17].
    18. Nguyen JD, Grant Y, Creehan KM, Vandewater SA, Taffe MA. Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions. Addict Biol. 2017 Sep; 22(5):1160-1168. PMID: 27046454.
      View in: PubMed
    19. Taffe MA. Drug abuse scientists should use social media to engage the public because their primary translational product is information. Drug Alcohol Depend. 2015 Sep 01; 154:315-9. PMID: 26488060.
      View in: PubMed
    20. Vandewater SA, Creehan KM, Taffe MA. Intravenous self-administration of entactogen-class stimulants in male rats. Neuropharmacology. 2015 Dec; 99:538-45. PMID: 26302654; PMCID: PMC4655153 [Available on 12/01/16].
    21. Miller ML, Aarde SM, Moreno AY, Creehan KM, Janda KD, Taffe MA. Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats. Drug Alcohol Depend. 2015 Aug 01; 153:29-36. PMID: 26118833.
      View in: PubMed
    22. Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA. In vivo potency and efficacy of the novel cathinone a-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology (Berl). 2015 Aug; 232(16):3045-55. PMID: 25925780.
      View in: PubMed
    23. Aarde SM, Miller ML, Creehan KM, Vandewater SA, Taffe MA. One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone. Drug Alcohol Depend. 2015 Jun 01; 151:151-8. PMID: 25863714; PMCID: PMC4447594.
    24. Taffe MA, Creehan KM, Vandewater SA. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by ?(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol. 2015 Apr; 172(7):1783-91. PMID: 25425111; PMCID: PMC4376456.
    25. Creehan KM, Vandewater SA, Taffe MA. Intravenous self-administration of mephedrone, methylone and MDMA in female rats. Neuropharmacology. 2015 May; 92:90-7. PMID: 25600245; PMCID: PMC4346510.
    26. Aarde SM, Huang PK, Dickerson TJ, Taffe MA. Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats. Psychopharmacology (Berl). 2015 Jun; 232(11):1867-77. PMID: 25424056.
      View in: PubMed
    27. Wright MJ, Taffe MA. Chronic periadolescent alcohol consumption produces persistent cognitive deficits in rhesus macaques. Neuropharmacology. 2014 Nov; 86:78-87. PMID: 25018042; PMCID: PMC4188799.
    28. Wright MJ, Vandewater SA, Taffe MA. Cannabidiol attenuates deficits of visuospatial associative memory induced by ?(9) tetrahydrocannabinol. Br J Pharmacol. 2013 Dec; 170(7):1365-73. PMID: 23550724; PMCID: PMC3838683.
    29. Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology. 2013 Aug; 71:130-40. PMID: 23597511; PMCID: PMC3681807.
    30. Aarde SM, Angrish D, Barlow DJ, Wright MJ, Vandewater SA, Creehan KM, Houseknecht KL, Dickerson TJ, Taffe MA. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol. 2013 Sep; 18(5):786-99. PMID: 23363010; PMCID: PMC3641159.
    31. Wright MJ, Vandewater SA, Parsons LH, Taffe MA. ?(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques. Neuroscience. 2013 Apr 03; 235:51-8. PMID: 23333671; PMCID: PMC3595391.
    32. Wright MJ, Vandewater SA, Taffe MA. The influence of acute and chronic alcohol consumption on response time distribution in adolescent rhesus macaques. Neuropharmacology. 2013 Jul; 70:12-8. PMID: 23321688; PMCID: PMC3636163.
    33. Wright MJ, Glavis-Bloom C, Taffe MA. Acute ethanol reduces reversal cost in discrimination learning by reducing perseverance in adolescent rhesus macaques. Alcohol Clin Exp Res. 2013 Jun; 37(6):952-60. PMID: 23298170; PMCID: PMC4455938.
    34. Wright MJ, Vandewater SA, Angrish D, Dickerson TJ, Taffe MA. Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques. Br J Pharmacol. 2012 Nov; 167(6):1342-52. PMID: 22748013; PMCID: PMC3504998.
    35. Miller ML, Moreno AY, Aarde SM, Creehan KM, Vandewater SA, Vaillancourt BD, Wright MJ, Janda KD, Taffe MA. A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats. Biol Psychiatry. 2013 Apr 15; 73(8):721-8. PMID: 23098894; PMCID: PMC3561477.
    36. Wright MJ, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Vandewater SA, Parsons LH, Houseknecht KL, Dickerson TJ, Taffe MA. Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats. PLoS One. 2012; 7(8):e44652. PMID: 22952999; PMCID: PMC3432134.
    37. Miller ML, Creehan KM, Angrish D, Barlow DJ, Houseknecht KL, Dickerson TJ, Taffe MA. Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). Drug Alcohol Depend. 2013 Jan 01; 127(1-3):248-53. PMID: 22832282; PMCID: PMC3491086.
    38. Huang PK, Aarde SM, Angrish D, Houseknecht KL, Dickerson TJ, Taffe MA. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):168-75. PMID: 22664136; PMCID: PMC3439532.
    39. Taffe MA. ??Tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques. J Psychopharmacol. 2012 Oct; 26(10):1299-306. PMID: 22526684; PMCID: PMC3560534.
    40. Taffe MA. ?9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys. Neuroscience. 2012 Jan 10; 201:125-33. PMID: 22138434; PMCID: PMC3258357.
    41. Miller ML, Vaillancourt BD, Wright MJ, Aarde SM, Vandewater SA, Creehan KM, Taffe MA. Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats. Drug Alcohol Depend. 2012 Feb 01; 121(1-2):90-6. PMID: 21899959; PMCID: PMC3235246.
    42. Taffe MA, Taffe WJ. Rhesus monkeys employ a procedural strategy to reduce working memory load in a self-ordered spatial search task. Brain Res. 2011 Sep 21; 1413:43-50. PMID: 21840507; PMCID: PMC3167000.
    43. Gilpin NW, Wright MJ, Dickinson G, Vandewater SA, Price JU, Taffe MA. Influences of activity wheel access on the body temperature response to MDMA and methamphetamine. Pharmacol Biochem Behav. 2011 Sep; 99(3):295-300. PMID: 21605589; PMCID: PMC3129476.
    44. Taffe MA. A comparison of intraperitoneal and subcutaneous temperature in freely moving rhesus macaques. Physiol Behav. 2011 Jul 06; 103(5):440-4. PMID: 21443893; PMCID: PMC3107936.
    45. Crean RD, Vandewater SA, Katner SN, Huitron-Resendiz S, Taffe MA. Chronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkeys. Drug Alcohol Depend. 2011 Mar 01; 114(1):31-40. PMID: 20951512; PMCID: PMC3024459.
    46. Taffe MA, Kotzebue RW, Crean RD, Crawford EF, Edwards S, Mandyam CD. Long-lasting reduction in hippocampal neurogenesis by alcohol consumption in adolescent nonhuman primates. Proc Natl Acad Sci U S A. 2010 Jun 15; 107(24):11104-9. PMID: 20534463; PMCID: PMC2890755.
    47. Marcondes MC, Watry D, Zandonatti M, Flynn C, Taffe MA, Fox H. Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res. 2008 Sep; 32(9):1583-92. PMID: 18616669; PMCID: PMC2579901.
    48. Katner SN, Von Huben SN, Davis SA, Lay CC, Crean RD, Roberts AJ, Fox HS, Taffe MA. Robust and stable drinking behavior following long-term oral alcohol intake in rhesus macaques. Drug Alcohol Depend. 2007 Dec 01; 91(2-3):236-43. PMID: 17628350; PMCID: PMC2231844.
    49. Crean RD, Davis SA, Taffe MA. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques. Pharmacol Biochem Behav. 2007 May; 87(1):11-9. PMID: 17475314; PMCID: PMC1975960.
    50. Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience. 2006 Oct 13; 142(2):515-25. PMID: 16876329; PMCID: PMC1853374.
    51. Roberts ES, Huitron-Resendiz S, Taffe MA, Marcondes MC, Flynn CT, Lanigan CM, Hammond JA, Head SR, Henriksen SJ, Fox HS. Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J Neurosci. 2006 Apr 26; 26(17):4577-85. PMID: 16641237.
      View in: PubMed
    52. Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA. Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology. 2007 Mar; 32(3):673-81. PMID: 16641942; PMCID: PMC2080863.
    53. Von Huben SN, Davis SA, Lay CC, Katner SN, Crean RD, Taffe MA. Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys. Psychopharmacology (Berl). 2006 Nov; 188(4):586-96. PMID: 16538469; PMCID: PMC2099258.
    54. Burdo TH, Katner SN, Taffe MA, Fox HS. Neuroimmunity, drugs of abuse, and neuroAIDS. J Neuroimmune Pharmacol. 2006 Mar; 1(1):41-9. PMID: 18040790.
      View in: PubMed
    55. Taffe MA. Peer review and new investigators. Science. 2006 Feb 10; 311(5762):775. PMID: 16469900.
      View in: PubMed
    56. Taffe MA, Lay CC, Von Huben SN, Davis SA, Crean RD, Katner SN. Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys. Drug Alcohol Depend. 2006 May 20; 82(3):276-81. PMID: 16289931; PMCID: PMC1551973.
    57. Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol. 2004 Dec; 157(1-2):81-92. PMID: 15579284.
      View in: PubMed
    58. Katner SN, Flynn CT, Von Huben SN, Kirsten AJ, Davis SA, Lay CC, Cole M, Roberts AJ, Fox HS, Taffe MA. Controlled and behaviorally relevant levels of oral ethanol intake in rhesus macaques using a flavorant-fade procedure. Alcohol Clin Exp Res. 2004 Jun; 28(6):873-83. PMID: 15201630; PMCID: PMC4070450.
    59. Katner SN, Davis SA, Kirsten AJ, Taffe MA. Effects of nicotine and mecamylamine on cognition in rhesus monkeys. Psychopharmacology (Berl). 2004 Sep; 175(2):225-40. PMID: 15112030; PMCID: PMC2121304.
    60. Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH. Modeling a task that is sensitive to dementia of the Alzheimer's type: individual differences in acquisition of a visuo-spatial paired-associate learning task in rhesus monkeys. Behav Brain Res. 2004 Mar 02; 149(2):123-33. PMID: 15129776.
      View in: PubMed
    61. Taffe MA. Effects of parametric feeding manipulations on behavioral performance in macaques. Physiol Behav. 2004 Mar; 81(1):59-70. PMID: 15059685.
      View in: PubMed
    62. Weed MR, Gold LH, Polis I, Koob GF, Fox HS, Taffe MA. Impaired performance on a rhesus monkey neuropsychological testing battery following simian immunodeficiency virus infection. AIDS Res Hum Retroviruses. 2004 Jan; 20(1):77-89. PMID: 15000701.
      View in: PubMed
    63. Madden LJ, Zandonatti MA, Flynn CT, Taffe MA, Marcondes MC, Schmitz JE, Reimann KA, Henriksen SJ, Fox HS. CD8+ cell depletion amplifies the acute retroviral syndrome. J Neurovirol. 2004; 10 Suppl 1:58-66. PMID: 14982741.
      View in: PubMed
    64. Taffe MA, Huitrón-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH. MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol Biochem Behav. 2003 Aug; 76(1):141-52. PMID: 13679227.
      View in: PubMed
    65. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol. 2003 Jun; 162(6):2041-57. PMID: 12759259; PMCID: PMC1868118.
    66. Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology. 2002 Dec; 27(6):993-1005. PMID: 12464456.
      View in: PubMed
    67. Burudi EM, Marcondes MC, Watry DD, Zandonatti M, Taffe MA, Fox HS. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains. J Virol. 2002 Dec; 76(23):12233-41. PMID: 12414962; PMCID: PMC136861.
    68. Taffe MA, Davis SA, Gutierrez T, Gold LH. Ketamine impairs multiple cognitive domains in rhesus monkeys. Drug Alcohol Depend. 2002 Oct 01; 68(2):175-87. PMID: 12234647; PMCID: PMC4085126.
    69. Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys. Psychopharmacology (Berl). 2002 Mar; 160(3):253-62. PMID: 11889494; PMCID: PMC4077277.
    70. Taffe MA, Weed MR, Davis S, Huitrón-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH. Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology. 2001 Mar; 24(3):230-9. PMID: 11166514.
      View in: PubMed
    71. Taffe MA, Weed MR, Gold LH. Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res. 1999 Oct 25; 8(3):203-12. PMID: 10556599.
      View in: PubMed
    72. Weed MR, Taffe MA, Polis I, Roberts AC, Robbins TW, Koob GF, Bloom FE, Gold LH. Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance. Brain Res Cogn Brain Res. 1999 Oct 25; 8(3):185-201. PMID: 10556598.
      View in: PubMed
    73. Gold LH, Fox HS, Henriksen SJ, Buchmeier MJ, Weed MR, Taffe MA, Huitrón-Resendiz S, Horn TF, Bloom FE. Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol. 1998 Apr-Jun; 27(2-3):104-12. PMID: 9747951.
      View in: PubMed